During Tuesday’s Current trade, Shares of Energy Transfer Partners LP(NYSE:ETP), lost -1.45% to $51.79.
Energy Transfer Partners, L.P. (ETP) offered further details on its formerly declared Revolution Project that will significantly enhance its operations in the growing Marcellus and Upper Devonian production areas of Western Pennsylvania. ETP has reached long-term gas gathering, processing, and fractionation agreements with EdgeMarc Energy. To facilitate these agreements, ETP has purchased about twenty miles of high pressure pipeline from EdgeMarc and will build a new cryogenic gas processing plant, a new fractionators and additional gas gathering pipelines.
ETP plans to construct about 100 miles of high pressure 24- and 30-inch rich gas pipeline providing a total gathering system capacity in excess of 440 million cubic feet per day. The Revolution Pipeline originates in Butler County, Pennsylvania and will extend to ETP’s Revolution Plant, a new cryogenic gas processing plant to be constructed in Western Pennsylvania. The Revolution Plant is predictable to be in-service by the second quarter of 2017 and will allow for future processing growth for additional third party gas.
Energy Transfer Partners, L.P. engages in the natural gas midstream, and intrastate transportation and storage businesses in the United States. The company’s Intrastate Transportation and Storage segment transports natural gas from various natural gas producing areas, in addition to through its ET fuel system and HPL system. This segment owns and operates about 7,700 miles of natural gas transportation pipelines and three natural gas storage facilities in Texas. Its Interstate Transportation and Storage segment provides natural gas transportation and storage services; owns and operates about 12,800 miles of interstate natural gas pipeline; and has interests various natural gas pipelines.
Shares of Becton, Dickinson and Co. (NYSE:BDX), declined -0.71% to $141.64, during its current trading session.
Becton, Dickinson and Co. (BDX) declared the successful implementation of the Alaris® System across all four WellSpan hospitals, with WellSpan York Hospital becoming the first hospital ever to simultaneously go-live with new infusion devices and bi-directional interoperability between the infusion device and the electronic health record (EHR).
Infusion device interoperability connects the health system’s Alaris System smart infusion pumps with the hospital’s EHR and is designed to assist reduce the risk of harmful and costly intravenous (IV) medication programming errors at the patient bedside. The solution enables bi-directional communication between the infusion pump and the EHR for both syringe pumps and large volume infusions.
Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The companys BD Medical segment produces medical devices, such as needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for use in the treatment of diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; and closed-system transfer devices.
T.Rowe Price Group Inc (NASDAQ:TROW), during its Tuesday’s current trading session decreased -1.09% to $76.09.
T. Rowe Price Group Inc (TROW)’s Retirement Saving & Spending Study revealed that a national sample of 1,505 millennials with 401(k)s have relatively good financial habits, particularly when compared with a national sample of 514 baby boomers with 401(k)s. While millennials are not saving at least 15% of their annual salary for retirement, as T. Rowe Price recommends, they recognize that saving for retirement is important and are interested in saving more.
More millennials than baby boomers track expenses carefully (75% vs. 64%) and stick to a budget (67% vs. 55%). And while baby boomers on average are saving a slightly higher percentage of their salary for retirement than millennials are saving, more millennials have raised their retirement savings within the past 12 months (40% vs. 21%). This suggests that they are acting in accordance with their financial priorities, as millennials ranked contributing to a 401(k) but below the match and paying down debt equally as their top priority.
T. Rowe Price Group, Inc. is a publicly owned asset administration holding company. The firm provides its services to individuals, institutional investors, retirement plans, financial intermediaries, and institutions. Through its auxiliaries, it launches and manages equity and fixed income mutual funds. The firm also launches balanced mutual funds and private equity funds.
Finally, Laboratory Corp. of America Holdings (NYSE:LH), decreased -0.72%, to $119.37.
Laboratory Corp. of America Holdings (LH) declared the expanded availability of its proprietary specimen collection and handling software, LabCorp AccuDraw®, to all clients through its website at www.LabCorp.com. Combining on-screen visual cues with step-by-step tutorials, AccuDraw is an innovative tool designed to guide the health care professional who collects patient specimens throughout the specimen collection process. AccuDrawassists to facilitate collection and appropriate stabilization of the correct specimen type and sample volume. This technology-enabled solution leads to fewer errors in specimen collection and processing, a reduced chance of delays in testing, and a lower likelihood of having a patient undergo a second visit to a health care professional for further specimen collection. AccuDraw has been used in LabCorp’s patient service centers and by LabCorp’s phlebotomists located in client locations for over five years. AccuDrawhas formerly only been, and will continue to be, accessible to LabCorp clients through the LabCorp Beacon® application.
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. The company offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, STD tests, HCV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by the medical profession in core testing, patient diagnosis, and in the monitoring and treatment of diseases.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
